Anuh Pharma Limited has informed the Exchange regarding Notice of Postal Ballot
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 0.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Anuh Pharma is seeking shareholder approval via postal ballot (e-voting from June 7 to July 6, 2025) to issue bonus shares in a 1:1 ratio, meaning 1 new equity share for every 1 existing share held. The company will capitalize up to ₹25.05 crore from its general reserve and/or retained earnings for this purpose. The face value of the shares is ₹5 each, and the move will double the issued, subscribed and paid-up share count from 5,01,12,000 to 10,02,24,000 shares. The company cited the successful commissioning of its new API-3 Plant and strong accumulated reserves as reasons for rewarding shareholders. The record date for eligibility is May 30, 2025, and results will be declared on or before July 8, 2025.
If approved, each shareholder will receive one additional share for every share they own, effectively doubling their share count while the stock price typically adjusts downward proportionally, leaving overall holding value largely unchanged. The bonus reflects management's confidence in future profitability from the new API-3 Plant and signals healthy reserves, which is generally viewed positively by retail investors.